Case Studies

Rare Oncology Diseases
Rare Oncology Diseases

This case study examines an M3 Global Research project for an end-client who wanted to understand the prevalence of certain treatments utilized by oncologists treating a rare disease. Read the case study to learn how M3 overcame some unique challenges to deliver a successful project outcome.

Cutaneous T Cell Lymphoma CTCL
Cutaneous T Cell Lymphoma CTCL

Working for a full-service market research company working with a clinical-stage biotechnology company focused on development of therapeutic antibodies for improvement in cancer treatment, M3 Global Research was seeking to secure “payers” to participate in the research focused on Cutaneous T Cell Lymphoma (CTCL). Learn more by reading this case study.

Mobile App photo
M3 CONFERENCE MOBILE APP

Our client was interested in helping their Pharma client gauge insight and reaction ‘in the moment’ to five specific abstracts or oral sessions, and conducting immediate response research with attendees soon after specific sessions ended.

MULTI-COUNTRY QUALITATIVE RESEARCH STUDY
MULTI-COUNTRY QUALITATIVE RESEARCH STUDY

M3 built on its extensive experience recruiting oncologists worldwide and expanded into a related audience in the community. The combined effort across US and EU M3 offices with local partners resulted in the successful recruitment of 50 leaders of patient advocacy groups across 28 countries.


m3 is a proud member and supporter of